Pharma Focus Asia

CASI Pharmaceuticals Acquires ANDA Portfolio From Sandoz Inc. (Sandoz)

Monday, January 29, 2018

CASI Pharmaceuticals, Inc., a biopharmaceutical company dedicated to bringing quality pharmaceutical products to the Chinese and U.S. markets announced today that it has acquired a portfolio of 25 U.S. FDA-approved abbreviated new drug applications (ANDAs), one ANDA that FDA tentatively approved, and three ANDAs that are pending FDA approval.  CASI intends to select and commercialize certain products from the portfolio that have unique market opportunity and cost-effective manufacturing in China and/or in the U.S.

Ken Ren, Ph.D., CASI's Chief Executive Officer commented, "The acquisition of the Sandoz ANDAs enhances our strategic focus to build a robust pipeline and commercialize quality drug candidates in China, including entecavir, an antiviral medication used in the treatment of hepatitis B viral infection ("HBV"), which unfortunately in China accounts for more than half of the estimated 700,000 HBV-related deaths worldwide each year.  With FDA-approved ANDA status and the high-quality standards of Sandoz, we anticipate leveraging the Chinese FDA's (CFDA) more recent regulations to accept western pharmaceutical and clinical data for rapid entry into China's market while being competitive in the marketplace."

Dr. Ren continued, "This is an exciting and unprecedented time in the CFDA regulatory landscape, against a backdrop of soaring demand in China for high quality import pharmaceuticals.  We are confident in our ability to launch certain products that we acquired from the Sandoz portfolio in China, along with our launch of EVOMELA®, MARQIBO® and ZEVALIN® all of which are in various stages of CFDA review. We look forward to completing our Company's transition from research and development to commercial."

magazine-slider-imageMFA + MMA 2024CPHI Chine || PMEC China 2024Asia Healthcare Week 2024Advance DoE WorkshopNitrosamine Advance Workshop 2024CPHI Korea 2024CHEMICAL INDONESIA 2024INALAB 2024 Thermo Scientific - DynaDrive and DynaSpinDigital Health Asia 2024Rehab Expo 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Pharmaceutical Manufacturing & Quality Conference2024 PDA Cell and Gene Pharmaceutical Products Conference 2024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals ConferencePharma Quality Excellence Awards 20244th Annual Pharma GMP Quality Management 20243rd World ADC Asia 2024LogiPharma Asia 2024